Source comparison
CJC-1295 No DAC Help Growth Hormone Pulse Research: Comparison of Research-Grade GHRH Analogues
CJC-1295 No DAC ~30 minutes Discrete pulses preserved Ultradian rhythm studies, sleep-stage GH dynamics, fasting protocols Per-pulse administration (every 3–5 hours) 200–300% above baseline pulse CJC-1295 DAC 6–8 days Tonic elevation, minimal pulsatility Anabo
This comparison does not assign a generated winner or score.
- CJC-1295 No DAC
- ~30 minutes
- Discrete pulses preserved
- Ultradian rhythm studies, sleep-stage GH dynamics, fasting protocols
- Per-pulse administration (every 3–5 hours)
- 200–300% above baseline pulse
- CJC-1295 DAC
- 6–8 days
- Tonic elevation, minimal pulsatility
- Anabolic protocols, sustained IGF-1 elevation studies
- Once weekly
- 30–50% sustained plateau
- Sermorelin (GHRH 1-29)
- ~10 minutes
- Single pulse amplification
- Acute secretagogue response testing
- Per-pulse (immediate pre-pulse)
- 150–200% single pulse
- Tesamorelin
- ~26 minutes
- Discrete pulses, clinical lipodystrophy context
- HIV-associated lipodystrophy research, visceral adipose protocols
- Daily (pre-sleep)
- 180–250% nocturnal pulse
- Native GHRH (1-44)
- 7 minutes
- Baseline endogenous pattern
- Receptor pharmacology, acute response assays
- Continuous infusion or frequent bolus
- 100% (baseline reference)